{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:56:15Z","timestamp":1774374975911,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.medcli.2011.12.019","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T05:30:01Z","timestamp":1332912601000},"page":"141-149","source":"Crossref","is-referenced-by-count":10,"title":["Leucemia linfobl\u00e1stica aguda T pedi\u00e1trica: an\u00e1lisis de supervivencia y factores pron\u00f3sticos en 4 protocolos consecutivos del grupo cooperativo multic\u00e9ntrico SHOP"],"prefix":"10.1016","volume":"139","author":[{"given":"Susana","family":"Rives","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Estella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Cam\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purificaci\u00f3n","family":"Garc\u00eda-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Verdeguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Couselo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Tasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fern\u00e1ndez-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Navajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Badell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2011.12.019_bib0005","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.12.019_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2009.257","article-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","volume":"24","author":"M\u00f6ricke","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.12.019_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.12.019_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group","volume":"339","author":"Cav\u00e9","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.12.019_bib0025","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2401555","article-title":"Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study","volume":"13","author":"Pullen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.12.019_bib0035","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medcli.2011.12.019_bib0045","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ng1425","article-title":"Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia","volume":"36","author":"Graux","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.medcli.2011.12.019_bib0050","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2009-07-235143","article-title":"Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia","volume":"115","author":"Sanda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0055","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":"Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90","volume":"28","author":"Tallen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12094-008-0165-1","article-title":"Long-term results of two consecutive trials in childhood acute lymphoblastic leukaemia performed by the Spanish Cooperative Group for Childhood Acute Lymphoblastic Leukemia Group (SHOP) from 1989 to 1998","volume":"10","author":"Badell","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0065","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2","article-title":"Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)","volume":"75","author":"Aric\u00f2","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2011.12.019_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V75.1.174.174","article-title":"Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia","volume":"75","author":"Pui","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.12.019_bib0080","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2141.2009.07853.x","article-title":"Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukemia: a report from the Israeli National ALL-Studies","volume":"147","author":"Stark","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0090","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI22477","article-title":"Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics","volume":"115","author":"Kager","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medcli.2011.12.019_bib0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1157\/13126214","article-title":"Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study","volume":"131","author":"Sancho","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.12.019_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-911X(199707)29:1<16::AID-MPO3>3.0.CO;2-V","article-title":"Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia","volume":"29","author":"Schultz","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.2009.07607.x","article-title":"FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma","volume":"145","author":"Park","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0115","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/leu.2009.64","article-title":"The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"23","author":"Larson Gedman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.12.019_bib0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","article-title":"Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951","volume":"103","author":"Cav\u00e9","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0125","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3324\/haematol.13291","article-title":"Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3\/HOX11L2 gene expression on outcome","volume":"93","author":"Ballerini","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2011.12.019_bib0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1157\/13083566","article-title":"Significado pron\u00f3stico de los subtipos inmunol\u00f3gicos de la leucemia aguda linfobl\u00e1stica T del adulto. Estudio de 81 pacientes","volume":"126","author":"Xicoy","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.12.019_bib0140","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2011.12.019_bib0145","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2011.12.019_bib0150","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2011.08783.x","volume":"154","author":"Rives","year":"2011","journal-title":"Br J Haematol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:39:37Z","timestamp":1593905977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775312001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0025775312001637"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2011.12.019","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}